As summarised in Fig. 8, we propose a mechanistic model in which dual targeting of CAV1 and AXL impairs the pro-survival signalling via STAT3, AMPKα, and RAC pathways, thereby promoting excessive autophagy and inducing cancer cell death to overcome TKI resistance in HCC. This evidence concerns the gene AXL and hepatocellular carcinoma.